{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:57:34Z","timestamp":1790276254203,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007299","name":"Bharathiar University","doi-asserted-by":"publisher","award":["BU.\/RUSA2.0\/BCTRC\/2020\/BCTRC-CT06"],"award-info":[{"award-number":["BU.\/RUSA2.0\/BCTRC\/2020\/BCTRC-CT06"]}],"id":[{"id":"10.13039\/501100007299","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11030-022-10490-w","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T17:29:32Z","timestamp":1657733372000},"page":"1297-1308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Screening of potent STAT3-SH2 domain inhibitors from JAK\/STAT compound library through molecular dynamics simulation"],"prefix":"10.1007","volume":"27","author":[{"given":"Suryaa","family":"Manoharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajithkumar","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedagiri","family":"Hemamalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2159-8198","authenticated-orcid":false,"given":"Ekambaram","family":"Perumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"10490_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.semcdb.2008.07.003","volume":"19","author":"PB Sehgal","year":"2008","unstructured":"Sehgal PB (2008) Paradigm shifts in the cell biology of STAT signaling. Semin Cell Dev Biol 19:329\u2013340. https:\/\/doi.org\/10.1016\/j.semcdb.2008.07.003","journal-title":"Semin Cell Dev Biol"},{"key":"10490_CR2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1039\/b606246f","volume":"2","author":"CP Lim","year":"2006","unstructured":"Lim CP, Cao X (2006) Structure, function, and regulation of STAT proteins. Mol Biosyst 2:536. https:\/\/doi.org\/10.1039\/b606246f","journal-title":"Mol Biosyst"},{"key":"10490_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/jcb.21475","volume":"102","author":"KM Quesnelle","year":"2007","unstructured":"Quesnelle KM, Boehm AL, Grandis JR (2007) STAT-mediated EGFR signaling in cancer. J Cell Biochem 102:311\u2013319. https:\/\/doi.org\/10.1002\/jcb.21475","journal-title":"J Cell Biochem"},{"key":"10490_CR4","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1038\/sj.onc.1203481","volume":"19","author":"T Decker","year":"2000","unstructured":"Decker T, Kovarik P (2000) Serine phosphorylation of STATs. Oncogene 19:2628\u20132637. https:\/\/doi.org\/10.1038\/sj.onc.1203481","journal-title":"Oncogene"},{"key":"10490_CR5","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","volume":"178","author":"PJ Murray","year":"2007","unstructured":"Murray PJ (2007) The JAK-STAT signaling pathway: input and output integration. J Immunol 178:2623\u20132629. https:\/\/doi.org\/10.4049\/jimmunol.178.5.2623","journal-title":"J Immunol"},{"key":"10490_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/00001813-200507000-00002","volume":"16","author":"N Jing","year":"2005","unstructured":"Jing N, Tweardy DJ (2005) Targeting Stat3 in cancer therapy. Anticancer Drugs 16:601\u2013607. https:\/\/doi.org\/10.1097\/00001813-200507000-00002","journal-title":"Anticancer Drugs"},{"key":"10490_CR7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1006\/bbrc.2000.3499","volume":"276","author":"M Weidler","year":"2000","unstructured":"Weidler M, Rether J, Anke T, Erkel G (2000) Inhibition of Interleukin-6 signaling and Stat3 activation by a new class of bioactive cyclopentenone derivatives. Biochem Biophys Res Commun 276:447\u2013453. https:\/\/doi.org\/10.1006\/bbrc.2000.3499","journal-title":"Biochem Biophys Res Commun"},{"key":"10490_CR8","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","volume":"13","author":"J Schust","year":"2006","unstructured":"Schust J, Sperl B, Hollis A et al (2006) Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 13:1235\u20131242. https:\/\/doi.org\/10.1016\/j.chembiol.2006.09.018","journal-title":"Chem Biol"},{"key":"10490_CR9","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.1038\/sj.onc.1207972","volume":"23","author":"S Giraud","year":"2004","unstructured":"Giraud S, Hurlstone A, Avril S, Coqueret O (2004) Implication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 gene. Oncogene 23:7391\u20137398. https:\/\/doi.org\/10.1038\/sj.onc.1207972","journal-title":"Oncogene"},{"key":"10490_CR10","doi-asserted-by":"publisher","first-page":"8004","DOI":"10.1074\/jbc.M111486200","volume":"277","author":"S Giraud","year":"2002","unstructured":"Giraud S, Bienvenu F, Avril S et al (2002) Functional interaction of STAT3 transcription factor with the coactivator NcoA\/SRC1a. J Biol Chem 277:8004\u20138011. https:\/\/doi.org\/10.1074\/jbc.M111486200","journal-title":"J Biol Chem"},{"key":"10490_CR11","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/nm.2250","volume":"16","author":"H Lee","year":"2010","unstructured":"Lee H, Deng J, Kujawski M et al (2010) STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nat Med 16:1421\u20131428. https:\/\/doi.org\/10.1038\/nm.2250","journal-title":"Nat Med"},{"key":"10490_CR12","unstructured":"Pensa S, Regis G, Boselli D, Novelli F, Poli V (2009) STAT1 and STAT3 in tumorigenesis: two sides of the same coin? In: JAK-STAT pathway in disease, 1st edn. CRC Press, Boca Raton, pp 100\u2013121"},{"key":"10490_CR13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/13543784.2017.1351941","volume":"26","author":"ALA Wong","year":"2017","unstructured":"Wong ALA, Hirpara JL, Pervaiz S et al (2017) Do STAT3 inhibitors have potential in the future for cancer therapy? Expert Opin Investig Drugs 26:883\u2013887. https:\/\/doi.org\/10.1080\/13543784.2017.1351941","journal-title":"Expert Opin Investig Drugs"},{"key":"10490_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1517\/13543780802565791","volume":"18","author":"P Yue","year":"2009","unstructured":"Yue P, Turkson J (2009) Targeting STAT3 in cancer: how successful are we? Expert Opin Investig Drugs 18:45\u201356. https:\/\/doi.org\/10.1517\/13543780802565791","journal-title":"Expert Opin Investig Drugs"},{"key":"10490_CR15","doi-asserted-by":"publisher","first-page":"45443","DOI":"10.1074\/jbc.M107527200","volume":"276","author":"J Turkson","year":"2001","unstructured":"Turkson J, Ryan D, Kim JS et al (2001) Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem 276:45443\u201345455. https:\/\/doi.org\/10.1074\/jbc.M107527200","journal-title":"J Biol Chem"},{"key":"10490_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1158\/1535-7163.MCT-05-0302","volume":"5","author":"N Jing","year":"2006","unstructured":"Jing N, Zhu Q, Yuan P et al (2006) Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer. Mol Cancer Ther 5:279\u2013286. https:\/\/doi.org\/10.1158\/1535-7163.MCT-05-0302","journal-title":"Mol Cancer Ther"},{"issue":"S1","key":"10490_CR17","first-page":"S1","volume":"1","author":"T Chiba","year":"2016","unstructured":"Chiba T (2016) Cronicon CANCER Opinion STAT3 inhibitors for cancer therapy\u2014the rationale and remained problems. EC Cancer 1(S1):S1\u2013S8","journal-title":"EC Cancer"},{"key":"10490_CR18","doi-asserted-by":"publisher","first-page":"32979","DOI":"10.1074\/jbc.M502694200","volume":"280","author":"J Turkson","year":"2005","unstructured":"Turkson J, Zhang S, Mora LB et al (2005) A novel platinum compound inhibits constitutive Stat3 signaling and induces cell cycle arrest and apoptosis of malignant cells. J Biol Chem 280:32979\u201332988. https:\/\/doi.org\/10.1074\/jbc.M502694200","journal-title":"J Biol Chem"},{"key":"10490_CR19","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.1073\/pnas.0609757104","volume":"104","author":"K Siddiquee","year":"2007","unstructured":"Siddiquee K, Zhang S, Guida WC et al (2007) Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci USA 104:7391\u20137396. https:\/\/doi.org\/10.1073\/pnas.0609757104","journal-title":"Proc Natl Acad Sci USA"},{"key":"10490_CR20","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1039\/b926359d","volume":"46","author":"H-M Lee","year":"2010","unstructured":"Lee H-M, Chan DS-H, Yang F et al (2010) Identification of natural product Fonsecin B as a stabilizing ligand of c-myc G-quadruplex DNA by high-throughput virtual screening. Chem Commun 46:4680. https:\/\/doi.org\/10.1039\/b926359d","journal-title":"Chem Commun"},{"key":"10490_CR21","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1002\/anie.200907360","volume":"49","author":"DS-H Chan","year":"2010","unstructured":"Chan DS-H, Lee H-M, Yang F et al (2010) Structure-based discovery of natural-product-like TNF-\u03b1 inhibitors. Angew Chem Int Ed 49:2860\u20132864. https:\/\/doi.org\/10.1002\/anie.200907360","journal-title":"Angew Chem Int Ed"},{"key":"10490_CR22","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1039\/c0cc04927a","volume":"47","author":"C-H Leung","year":"2011","unstructured":"Leung C-H, Chan DS-H, Yang H et al (2011) A natural product-like inhibitor of NEDD8-activating enzyme. Chem Commun 47:2511. https:\/\/doi.org\/10.1039\/c0cc04927a","journal-title":"Chem Commun"},{"key":"10490_CR23","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/j.biochi.2012.06.004","volume":"94","author":"H-J Zhong","year":"2012","unstructured":"Zhong H-J, Pui-Yan Ma V, Cheng Z et al (2012) Discovery of a natural product inhibitor targeting protein neddylation by structure-based virtual screening. Biochimie 94:2457\u20132460. https:\/\/doi.org\/10.1016\/j.biochi.2012.06.004","journal-title":"Biochimie"},{"key":"10490_CR24","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1039\/c2cs35357a","volume":"42","author":"D-L Ma","year":"2013","unstructured":"Ma D-L, Chan DS-H, Leung C-H (2013) Drug repositioning by structure-based virtual screening. Chem Soc Rev 42:2130. https:\/\/doi.org\/10.1039\/c2cs35357a","journal-title":"Chem Soc Rev"},{"key":"10490_CR25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrd4088","volume":"12","author":"G Miklossy","year":"2013","unstructured":"Miklossy G, Hilliard TS, Turkson J (2013) Therapeutic modulators of STAT signalling for human diseases. Nat Rev Drug Discov 12:611\u2013629. https:\/\/doi.org\/10.1038\/nrd4088","journal-title":"Nat Rev Drug Discov"},{"key":"10490_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s13721-020-00262-7","volume":"9","author":"O Iwaloye","year":"2020","unstructured":"Iwaloye O, Elekofehinti OO, Momoh AI et al (2020) In silico molecular studies of natural compounds as possible anti-Alzheimer\u2019s agents: ligand-based design. Netw Model Anal Health Inform Bioinform 9:54. https:\/\/doi.org\/10.1007\/s13721-020-00262-7","journal-title":"Netw Model Anal Health Inform Bioinform"},{"key":"10490_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s40203-020-00054-x","volume":"8","author":"O Iwaloye","year":"2020","unstructured":"Iwaloye O, Elekofehinti OO, Oluwarotimi EA et al (2020) Insight into glycogen synthase kinase-3\u03b2 inhibitory activity of phyto-constituents from Melissa officinalis: in silico studies. In Silico Pharmacol 8:2. https:\/\/doi.org\/10.1007\/s40203-020-00054-x","journal-title":"In Silico Pharmacol"},{"key":"10490_CR28","volume-title":"LigPrep","author":"Schr\u00f6dinger","year":"2018","unstructured":"Schr\u00f6dinger (2018) LigPrep. Schr\u00f6dinger, LLC, New York"},{"key":"10490_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","volume":"12","author":"E Harder","year":"2016","unstructured":"Harder E, Damm W, Maple J et al (2016) OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. J Chem Theory Comput 12:281\u2013296. https:\/\/doi.org\/10.1021\/acs.jctc.5b00864","journal-title":"J Chem Theory Comput"},{"key":"10490_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1747-0285.2005.00327.x","volume":"67","author":"W Sherman","year":"2006","unstructured":"Sherman W, Beard HS, Farid R (2006) Use of an induced fit receptor structure in virtual screening. Chem Biol Drug Des 67:83\u201384. https:\/\/doi.org\/10.1111\/j.1747-0285.2005.00327.x","journal-title":"Chem Biol Drug Des"},{"key":"10490_CR31","doi-asserted-by":"publisher","first-page":"16076","DOI":"10.1021\/acsomega.0c01581","volume":"5","author":"NA Dur\u00e1n-Iturbide","year":"2020","unstructured":"Dur\u00e1n-Iturbide NA, D\u00edaz-Eufracio BI, Medina-Franco JL (2020) In silico ADME\/Tox profiling of natural products: a focus on BIOFACQUIM. ACS Omega 5:16076\u201316084. https:\/\/doi.org\/10.1021\/acsomega.0c01581","journal-title":"ACS Omega"},{"key":"10490_CR32","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"10490_CR33","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1097\/00005537-200005000-00016","volume":"110","author":"J Rubin Grandis","year":"2000","unstructured":"Rubin Grandis J, Zeng Q, Drenning SD (2000) Epidermal growth factor receptor-mediated Stat3 signaling blocks apoptosis in head and neck cancer. Laryngoscope 110:868\u2013874. https:\/\/doi.org\/10.1097\/00005537-200005000-00016","journal-title":"Laryngoscope"},{"key":"10490_CR34","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/00007890-200208150-00017","volume":"74","author":"RR Nepomuceno","year":"2002","unstructured":"Nepomuceno RR, Snow AL, Robert Beatty P et al (2002) Constitutive activation of Jak\/STAT proteins in Epstein-Barr virus-infected B-cell lines from patients with posttransplant lymphoproliferative disorder1. Transplantation 74:396\u2013402. https:\/\/doi.org\/10.1097\/00007890-200208150-00017","journal-title":"Transplantation"},{"key":"10490_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.imlet.2007.01.008","volume":"109","author":"A Samaan","year":"2007","unstructured":"Samaan A, Mahana W (2007) Constitutive and induced activation of JAK\/Stat pathway in leukemogenic and asymptomatic human T-cell lymphotropic virus type 1 (HTLV-1) transformed rabbit cell lines. Immunol Lett 109:113\u2013119. https:\/\/doi.org\/10.1016\/j.imlet.2007.01.008","journal-title":"Immunol Lett"},{"key":"10490_CR36","doi-asserted-by":"publisher","first-page":"12511","DOI":"10.1128\/JVI.01294-14","volume":"88","author":"YM B\u00e1ez-Santos","year":"2014","unstructured":"B\u00e1ez-Santos YM, Mielech AM, Deng X et al (2014) Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East Respiratory Syndrome Coronavirus. J Virol 88:12511\u201312527. https:\/\/doi.org\/10.1128\/JVI.01294-14","journal-title":"J Virol"},{"key":"10490_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2018.00043","author":"I Maffucci","year":"2018","unstructured":"Maffucci I, Hu X, Fumagalli V, Contini A (2018) An efficient implementation of the Nwat-MMGBSA method to rescore docking results in medium-throughput virtual screenings. Front Chem. https:\/\/doi.org\/10.3389\/fchem.2018.00043","journal-title":"Front Chem"},{"key":"10490_CR38","doi-asserted-by":"publisher","first-page":"366","DOI":"10.22270\/JDDT.V9I2-S.2710","volume":"9","author":"S Mishra","year":"2019","unstructured":"Mishra S, Dahima R (2019) In vitro ADME studies of TUG-891, a GPR-120 inhibitor using SwissADME predictor. J Drug Deliv Ther 9:366\u2013369. https:\/\/doi.org\/10.22270\/JDDT.V9I2-S.2710","journal-title":"J Drug Deliv Ther"},{"key":"10490_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3\u201325. https:\/\/doi.org\/10.1016\/S0169-409X(96)00423-1","journal-title":"Adv Drug Deliv Rev"},{"key":"10490_CR40","doi-asserted-by":"publisher","first-page":"745","DOI":"10.4155\/fmc.13.61","volume":"5","author":"J Baell","year":"2013","unstructured":"Baell J, Congreve M, Leeson P, Abad-Zapatero C (2013) Ask the Experts: past, present and future of the rule of five. Future Med Chem 5:745\u2013752. https:\/\/doi.org\/10.4155\/fmc.13.61","journal-title":"Future Med Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-022-10490-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-022-10490-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-022-10490-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T11:14:21Z","timestamp":1686914061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-022-10490-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10490"],"URL":"https:\/\/doi.org\/10.1007\/s11030-022-10490-w","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"assertion":[{"value":"28 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}